A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis.

An IgA monoclonal antibody (MUM/F1-1/copenhageni) was produced from a mouse immunised with Leptospira interrogans serovar copenhageni. The antibody showed partial serogroup specificity by agglutination and by reaction in enzyme immunoassay, and opsonised homologous leptospires for phagocytosis by cultured mouse macrophages. Immunodiffusion and Western-blotting experiments indicated that MUM/F1-1/copenhageni reacted with a carbohydrate determinant in the leptospiral lipopolysaccharide. Daily administration of purified MUM/F1-1/copenhageni IgA before and after challenge with 2 X 10(8) virulent homologous leptospires passively protected newborn guinea pigs against lethal leptospirosis.

[1]  B. Adler,et al.  The antibodies involved in the human immune response to leptospiral infection. , 1978, Journal of medical microbiology.

[2]  V. Nussenzweig,et al.  Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection , 1980, The Journal of experimental medicine.

[3]  C. Frasch,et al.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. , 1982, Analytical biochemistry.

[4]  B. Adler,et al.  The Role of Macrophages in the Protection of Mice Against Leptospirosis: In Vitro and In Vivo Studies , 1982, Pathology.

[5]  B. Adler,et al.  Ultrastructure and chemical composition of lipopolysaccharide extracted from Leptospira interrogans serovar copenhageni. , 1986, Journal of general microbiology.

[6]  T. Kirkland,et al.  An immunoprotective monoclonal antibody to lipopolysaccharide. , 1984, Journal of immunology.

[7]  S. Michalek,et al.  Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. , 1984, Journal of Immunology.

[8]  E. Ono,et al.  Production and characterization of monoclonal antibodies to lipopolysaccharide antigen of Leptospira interrogans serovar kremastos and canicola. , 1982, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

[9]  S Faine,et al.  Opsonic monoclonal antibodies against lipopolysaccharide antigens of Leptospira interrogans serovar hardjo. , 1987, Journal of medical microbiology.

[10]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .

[11]  B. Adler,et al.  Comparative studies on two antigens (F4 and TM) extracted from leptospires , 1980, Journal of clinical microbiology.

[12]  S. Faine,et al.  VIRULENCE-LINKED COLONIAL AND MORPHOLOGICAL VARIATION IN LEPTOSPIRA , 1964, Journal of bacteriology.

[13]  E. Ono,et al.  Isolation of an antigenic oligosaccharide fraction from Leptospira interrogans serovar canicola with a monoclonal antibody. , 1984, Journal of general microbiology.

[14]  B. Adler,et al.  Serological and protective-antibody responses of rabbits to leptospiral antigens. , 1978, Journal of medical microbiology.

[15]  T. Hofstad,et al.  Chemical studies of partially hydrolysed lipopolysaccharides from four strains of Campylobacter jejuni and two strains of Campylobacter coli. , 1984, Journal of general microbiology.

[16]  H. Muller,et al.  MATURATION OF HUMORAL IMMUNE RESPONSE DETERMINES THE SUSCEPTIBILITY OF GUINEA‐PIGS TO LEPTOSPIROSIS , 1980, Pathology.

[17]  B. Adler,et al.  Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona , 1976, Infection and immunity.

[18]  B. Adler,et al.  A POMONA SEROGROUP‐SPECIFIC, AGGLUTINATING ANTIGEN IN LEPTOSPIRA, IDENTIFIED BY MONOCLONAL ANTIBODIES , 1983, Pathology.

[19]  B. Adler,et al.  Host immunological mechanisms in the resistance of mice to leptospiral infections , 1977, Infection and immunity.

[20]  J. Pennington,et al.  Mechanism for pulmonary protection by lipopolysaccharide pseudomonas vaccine. , 1980, The Journal of infectious diseases.

[21]  J. Goding,et al.  Monoclonal Antibodies: Principles and Practice , 1996 .

[22]  C. Newbold,et al.  Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide , 1982, Infection and immunity.

[23]  Y. Masuho,et al.  Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins. , 1984, The Journal of infectious diseases.

[24]  Yuzuru Kobayashi,et al.  Characterization of Monoclonal Antibodies against Etiological Agents of Weil's Disease , 1984, Microbiology and immunology.

[25]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Weintraub,et al.  Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide , 1984, Journal of clinical microbiology.

[27]  R. Hawkes,et al.  A dot-immunobinding assay for monoclonal and other antibodies. , 1982, Analytical biochemistry.

[28]  M. Shinagawa,et al.  Isolation and Characterization of a Leptospiral Type-Specific Antigen , 1972, Infection and immunity.

[29]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[30]  B. Adler,et al.  PHAGOCYTOSIS OF VIRULENT AND AVIRULENT LEPTOSPIRES BY GUINEA‐PIG AND HUMAN POLYMORPHONUCLEAR LEUKOCYTES IN VITRO , 1984, Pathology.